TriMas Corporation (NASDAQ:TRS - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2026 EPS estimates for shares of TriMas in a research report issued on Wednesday, June 25th. Zacks Research analyst M. Das now anticipates that the industrial products company will post earnings of $0.51 per share for the quarter, down from their prior estimate of $0.55. The consensus estimate for TriMas' current full-year earnings is $1.69 per share.
A number of other research firms also recently weighed in on TRS. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. BWS Financial restated a "buy" rating and issued a $40.00 target price on shares of TriMas in a report on Wednesday, April 30th.
Check Out Our Latest Stock Analysis on TriMas
TriMas Stock Performance
TriMas stock opened at $28.38 on Monday. The company's 50-day moving average price is $25.36 and its 200-day moving average price is $24.10. TriMas has a twelve month low of $19.33 and a twelve month high of $28.77. The company has a quick ratio of 1.49, a current ratio of 2.82 and a debt-to-equity ratio of 0.63. The company has a market cap of $1.15 billion, a PE ratio of 36.86 and a beta of 0.61.
TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.03. TriMas had a net margin of 3.36% and a return on equity of 10.54%. The company had revenue of $241.67 million for the quarter, compared to the consensus estimate of $235.41 million. During the same period in the previous year, the firm posted $0.37 EPS. TriMas's revenue for the quarter was up 6.4% compared to the same quarter last year.
TriMas Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Tuesday, May 6th. This represents a $0.16 annualized dividend and a yield of 0.56%. TriMas's payout ratio is 20.78%.
Insider Activity at TriMas
In related news, Director Adrianne Shapira acquired 4,000 shares of the stock in a transaction on Thursday, June 5th. The stock was bought at an average cost of $25.82 per share, with a total value of $103,280.00. Following the transaction, the director now directly owns 8,476 shares in the company, valued at approximately $218,850.32. This represents a 89.37% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Shawn Sedaghat purchased 123,388 shares of the stock in a transaction dated Wednesday, April 30th. The stock was acquired at an average cost of $23.83 per share, with a total value of $2,940,336.04. Following the transaction, the director now directly owns 1,024,362 shares in the company, valued at approximately $24,410,546.46. This trade represents a 13.69% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 971,649 shares of company stock worth $24,585,343. Insiders own 14.20% of the company's stock.
Institutional Investors Weigh In On TriMas
Several hedge funds have recently modified their holdings of the business. Jane Street Group LLC purchased a new stake in shares of TriMas in the 1st quarter worth approximately $868,000. Nexpoint Asset Management L.P. purchased a new stake in shares of TriMas in the 1st quarter worth approximately $2,334,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of TriMas by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,120 shares of the industrial products company's stock worth $565,000 after purchasing an additional 1,014 shares during the period. Alta Fox Capital Management LLC purchased a new stake in shares of TriMas in the 1st quarter worth approximately $17,385,000. Finally, Ancora Advisors LLC purchased a new stake in shares of TriMas in the 1st quarter worth approximately $351,000. Hedge funds and other institutional investors own 99.42% of the company's stock.
TriMas Company Profile
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.